It is a consumer goods private limited company based in Mumbai, Maharashtra, India, established in 2012.
2012 | Mumbai, Maharashtra, India | ActiveRelichem Pharma Private Limited, a active private limited company, was established on 13 September 2012 in Mumbai, Maharashtra, India. Engaging in health & beauty retail & distribution within the manufacturing sector, it holds CIN: U74120MH2012PTC235716. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹1.82 Cr.
It upholds a active non-compliant status. Its leadership includes Rajendrakumar Satyanarayan Holani (Additional Director), Suresh Chand Mandhana (Additional Director), Rohitash Kailashchand Mandhana (Director). Past directors included Tapan Kumar Kashyap. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at 411, Atlanta Estate, G.M. Link Road, Near Virwani W.E.Highway, Goregaon (East),, Mumbai, Maharashtra, 400063.
U74120MH2012PTC235716
235716
13 September 2012
₹4.00 Cr
₹1.82 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Relichem Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajendrakumar Satyanarayan Holani | Additional Director | 10 Jan 2017 | Current |
| Suresh Chand Mandhana | Additional Director | 27 Feb 2015 | Current |
| Rohitash Kailashchand Mandhana | Director | 13 Sep 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Mar 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Relichem Pharma Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 79.38% increase in profit. The company's net worth dipped by a decrease of 0.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Relichem Pharma had a promoter holding of 85.24% and a public holding of 14.76%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Relichem Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Relichem Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relichem Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Relichem Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was recorded as a recent event.
Progress on Relichem Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Mumbai. was documented.
Rajendrakumar Satyanarayan Holani was appointed as a Additional Director was appointed as a Additional Director on 10 Jan 2017 & has been associated with this company since 8 years 10 months . was recorded as a recent event.
Progress on Suresh Chand Mandhana was appointed as a Additional Director was appointed as a Additional Director on 27 Feb 2015 & has been associated with this company since 10 years 9 months . was documented.
The activity Rohitash Kailashchand Mandhana was appointed as a Director was appointed as a Director on 13 Sep 2012 & has been associated with this company since 13 years 2 months . was completed.
Relichem Pharma Private Limited was registered on 13 Sep 2012 with Roc Mumbai & aged 13 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Relichem Pharma Private Limited is U74120MH2012PTC235716.
Relichem Pharma Private Limited is headquartered at 411, Atlanta Estate, G.M. Link Road, Near Virwani W.E.Highway, Goregaon (East),, Mumbai, Maharashtra, 400063.
Relichem Pharma Private Limited was incorporated on 13 September 2012.
The current directors of Relichem Pharma Private Limited are
The primary industry of Relichem Pharma Private Limited is Manufacturing.
Relichem Pharma Private Limited is unlisted.
The authorized capital of Relichem Pharma Private Limited is ₹4.00 Cr, and the paid-up capital is ₹1.82 Cr.
The compliance status of Relichem Pharma Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX